Sun Pharma’s agreement to acquire all outstanding shares of NYSE-listed Organon & Co for $14 per share in a cash deal, implies an enterprise value of $11.75 billion for Organon.…
Category: Companies
Beauty brand WishCare in early talks to sell majority stake at ₹3,000 crore valuation
Kolkata-based WishCare, known for its range of serums, sunscreens, and hair growth products, is exploring a majority stake sale that will value the brand at about ₹3,000-3,500 crore, three people…
Why Sun Pharma’s massive Organon buyout is winning over investors where Lupin, Biocon failed
Sun Pharmaceutical Industries Ltd’s acquisition of Organon might yet avoid the pitfalls that its rivals, Lupin Ltd and Biocon Ltd, have faced in the past. Billed as among the largest…
Snabbit raises $56 million in Series D; valuation doubles to $360 million
Quick home services startup Snabbit has raised $56 million as part of its Series D round, co-led by Susquehanna Venture Capital, Mirae Asset Venture Investments’ (MAVI), Unicorn Growth Fund, and…
Indian IT increases vigil on deal conversations even as AI eats revenue
In a shift from the ‘growth at any cost’ era, IT services industry leaders like Infosys Ltd, HCL Technologies Ltd, and Tech Mahindra Ltd are increasingly avoiding low-margin contracts, preferring…
Disney CEO faces first Trump test as President and Melania demand ABC fire Jimmy Kimmel over ‘expectant widow’ joke
New Disney chief Josh D’Amaro, barely six weeks into the role, is navigating his first major political crisis. US President Donald Trump and First Lady Melania Trump publicly called on…
Diet Coke shortage gives zero-sugar D2C beverages a summer opportunity
A nationwide shortage of Diet Coke is creating an opportunity for India’s direct-to-consumer zero-sugar beverage brands to win new customers as supply disruptions leave multinational soda makers short on shelves…
Alvarez & Marsal looks to deepen India presence over the next year
MUMBAI: Alvarez & Marsal (A&M) plans to scale up its corporate finance team in India and expand into new sectors, as the New York-based consulting firm positions itself to capture…
Dilip Shanghvi-led Sun Pharma’s most expensive M&A deal signals fading allure of US generics business
Sun Pharmaceutical Industries Ltd on Monday announced the $11.75 billion acquisition of Organon & Co., in a seemingly aggressive push into the US market that has long decided the global…
Sun Pharma’s Organon buy took shape over three months of intense negotiations
Mumbai: India’s second-biggest overseas acquisition was stitched together over three months of near-daily negotiations between the bidder, the seller and their bankers, said a banker aware of the details behind…